JD Health and Innovent Biologics have forged a strategic partnership, encompassing deep integration across supply chain management, omni-channel sales, digital marketing, and other key areas. The aim is to elevate the efficacy and accessibility of pharmaceuticals and health services. The core focus of this collaboration includes disseminating health education on weight management and blood sugar control, as well as exploring synergies in the realm of oncology and other diseases. Innovent Biologics' latest weight-loss drug, "Mazdutide," is now exclusively available on JD Health and will be distributed through JD's extensive network of pharmaceutical cold chain warehouses spanning over 300 cities nationwide. Looking ahead, both parties will collaborate with leading experts and institutions to foster a greater public understanding of metabolic disorders and their respective treatments.